TBVI has coordinated the development of several new tools to support future TB vaccine clinical trials. Experts in the field together with researchers from the ongoing EDCTP-funded TB vaccine [...]
Vaccines protect people of all ages against disease. Immunization saves millions of lives every year and vaccines are widely recognized as one of the most successful health interventions. Yet, [...]
TBVI and EVI are building on a strong TB vaccine R&D community To discover and develop the next generation of TB vaccines it will be essential to build on the track record of European [...]
Developing a vaccine is a time-consuming and complex process, requiring a combination of specialized skills and technical capacities not readily available at a single organization. TRANSVAC2, [...]
NIAID has a new funding opportunity “Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed)”. For any questions, applicants are strongly encouraged to contact [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: 0031 (0)6 1099 5196
